Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 87 entries
View as:

A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01906658 Org: User:
Start: 07/31/13 End: 12/31/14 Due: 12/31/15

Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02561650 Org: User:
Start: 12/31/11 End: 12/31/11 Due: 12/31/12

Acthar Gel in Participants With Pulmonary Sarcoidosis

Phase: N/A Priority: Normal
NCT ID: NCT03320070 Org: User:
Start: 02/21/18 End: 11/15/21 Due: 11/15/22

Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT00879645 Org: User:
Start: 08/31/09 End: 03/31/10 Due: 03/31/11

Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02919761 Org: User:
Start: 11/07/16 End: 02/13/19 Due: 02/13/20

U.S. Study of Fibrocaps in Surgical Hemostasis

Phase: N/A Priority: Normal
NCT ID: NCT01256164 Org: User:
Start: 12/31/10 End: 10/31/11 Due: 10/31/12

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

Phase: N/A Priority: Normal
NCT ID: NCT03656692 Org: User:
Start: 10/05/18 End: 07/14/20 Due: 07/14/21

Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse

Phase: N/A Priority: Normal
NCT ID: NCT02633033 Org: User:
Start: 11/24/15 End: 05/09/19 Due: 05/09/20

Safety and Efficacy Study of Acthar in Subjects With ARDS

Phase: N/A Priority: Normal
NCT ID: NCT02113735 Org: User:
Start: 08/31/14 End: 08/31/16 Due: 08/31/17

Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00060450 Org: User:
Start: 08/31/01 End: 09/30/06 Due: 09/30/07

Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02561741 Org: User:
Start: 12/31/12 End: 12/31/12 Due: 12/31/13

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00549042 Org: User:
Start: 10/31/07 End: 01/31/09 Due: 01/31/10

Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00853320 Org: User:
Start: 02/28/03 End: 02/28/03 Due: 02/28/04

Study of the Efficacy and Safety of Intravenous vs Oral Acetaminophen for Treatment of Fever in Healthy Adult Males

Phase: N/A Priority: Normal
NCT ID: NCT00564629 Org: User:
Start: 08/31/07 End: 10/31/07 Due: 10/31/08

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

Phase: N/A Priority: Normal
NCT ID: NCT02770716 Org: User:
Start: 07/13/16 End: 07/24/19 Due: 07/24/20

Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.

Phase: N/A Priority: Normal
NCT ID: NCT01173627 Org: User:
Start: 08/31/06 End: 08/31/06 Due: 08/31/07

Topical Raplixa for Surgical Bleeding in Children

Phase: N/A Priority: Normal
NCT ID: NCT02117349 Org: User:
Start: 12/04/14 End: 03/06/18 Due: 03/06/19

Nitric Oxide in Myocardial Infarction Size

Phase: N/A Priority: Normal
NCT ID: NCT00568061 Org: User:
Start: 06/30/06 End: 06/30/08 Due: 06/30/09

Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients

Phase: N/A Priority: Normal
NCT ID: NCT00598559 Org: User:
Start: 01/31/08 End: 11/30/08 Due: 11/30/09

Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00853554 Org: User:
Start: 12/31/02 End: 12/31/02 Due: 12/31/03

Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease

Phase: N/A Priority: Normal
NCT ID: NCT01753401 Org: User:
Start: 01/31/13 End: 10/31/15 Due: 10/31/16

Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)

Phase: N/A Priority: Normal
NCT ID: NCT01722864 Org: User:
Start: 11/30/12 End: 08/31/13 Due: 08/31/14

Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide

Phase: N/A Priority: Normal
NCT ID: NCT00041574 Org: User:
Start: 04/30/02 End: 12/31/05 Due: 12/31/06

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Phase: N/A Priority: Normal
NCT ID: NCT00089570 Org: User:
Start: 06/30/04 End: 09/30/06 Due: 09/30/07

Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01993875 Org: User:
Start: 10/31/13 End: 01/31/14 Due: 01/31/15